Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Institut du Cancer de Montpellier - Val d'Aurelle
Imperial College London
M.D. Anderson Cancer Center
Natera, Inc.
University of Alabama at Birmingham
Seagen Inc.
City of Hope Medical Center
University Health Network, Toronto
Washington University School of Medicine
Washington University School of Medicine
Sensei Biotherapeutics, Inc.
Jonsson Comprehensive Cancer Center
Leap Therapeutics, Inc.
University of Alabama at Birmingham
Revolution Medicines, Inc.
Arbeitsgemeinschaft medikamentoese Tumortherapie
Elevation Oncology
Labcorp Corporation of America Holdings, Inc
UNC Lineberger Comprehensive Cancer Center
Taproot Health
UNC Lineberger Comprehensive Cancer Center
DxTerity Diagnostics
Cedars-Sinai Medical Center
Universitair Ziekenhuis Brussel
M.D. Anderson Cancer Center
Genmab
Kineta Inc.
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Exact Sciences Corporation
Main Line Health
Holy Name Medical Center, Inc.
SpeciCare
Albert Einstein College of Medicine
M.D. Anderson Cancer Center
Instituto do Cancer do Estado de São Paulo
Instituto do Cancer do Estado de São Paulo
Bay Area Gynecology Oncology
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
Duke University
Ohio State University Comprehensive Cancer Center
Edward-Elmhurst Health System
Memorial Sloan Kettering Cancer Center
ImmunoFrontier, Inc.
St. Luke's-Roosevelt Hospital Center
University of Copenhagen